Bonk, Inc. (NASDAQ:BNKK) Sees Large Decrease in Short Interest

Bonk, Inc. (NASDAQ:BNKK) saw a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 193,599 shares, a decrease of 36.6% from the July 15th total of 305,481 shares. Currently, 5.0% of the company’s stock are sold short. Based on an average daily trading volume, of 58,461 shares, the short-interest ratio is presently 3.3 days.

Bonk Price Performance

BNKK stock opened at $1.06 on Thursday. The stock has a market capitalization of $8.48 million, a P/E ratio of -0.28 and a beta of 1.98. Bonk has a 1-year low of $0.91 and a 1-year high of $18.20. The business has a fifty day moving average price of $1.25 and a 200-day moving average price of $2.24.

Bonk (NASDAQ:BNKK) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.76) EPS for the quarter. Bonk had a negative net margin of 952.21% and a negative return on equity of 137.47%. The business had revenue of $1.16 million for the quarter.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on BNKK. Wall Street Zen upgraded Bonk from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. Weiss Ratings reissued a “sell (e+)” rating on shares of Bonk in a research note on Friday, July 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Bonk currently has an average rating of “Sell”.

Institutional Trading of Bonk

A number of institutional investors have recently made changes to their positions in BNKK. State Street Corp purchased a new position in shares of Bonk during the fourth quarter valued at approximately $33,000. Steward Partners Investment Advisory LLC bought a new position in Bonk during the fourth quarter valued at approximately $37,000. BlackRock Inc. purchased a new stake in Bonk in the second quarter worth approximately $50,000. Jane Street Group LLC purchased a new stake in Bonk in the fourth quarter worth approximately $96,000. Finally, Geode Capital Management LLC bought a new stake in Bonk in the 4th quarter worth approximately $128,000. Hedge funds and other institutional investors own 12.55% of the company’s stock.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.